Alejandro Gomez Pinillos

New York University School of Medicine

Address Show details

Share |

Summary Information

Hematology/oncology clinics of North America (1)

8,306,749

Maven is an online database of international healthcare professionals. Records are downloadable to Excel or in-house database, with email, postal address and phone/fax contacts.

To view and export full contact details of healthcare professionals you must subscribe to Maven Semantic. To learn more please request a call from our team:

Request a call Brochure

Sources

mTOR Signaling Pathway and mTOR Inhibitors in Cancer Therapy.

(2012)

Journal - Hematology/oncology clinics of North America (United States )

Abstract :

Mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase. It is ubiquitously expressed in cells and is a therapeutic target for the cancer treatment arsenal. Despite the great responses obtained in tumors addicted to specific mutations or overactivation of key members of the mTOR pathway (HiF1a in RCC, cyclin D1 in MCL, or TSC in SEGA), mTOR inhibitors as single agents have modest activity. Dual PI3K/mTOR kinase inhibitors have been developed with the idea of overcoming resistance to the mTOR inhibition through preventing the activation of PI3K/Akt as a result of release negative feedback loops.Copyright © 2012 Elsevier Inc. All rights reserved.

ISSN :	1558-1977